Salute e Benessere

12 Posters and Presentations Featuring MolecuLight to be Presented at the SAWC…

The clinical presentation and posters featuring the MolecuLight i:X and DX from SAWC Fall 2023 are as follows:CLINICAL PRESENTATIONS The clinical presentation and posters featuring the MolecuLight i: XandDXfrom SAWC Fall 2023 are as follows: CLINICAL PRESENTATIONS b) CLINICALPOSTERS In addition to the clinical posters and presentations atSAWC Fall 2023, the MolecuLight i: X®andDX ™ imaging devices will be available for demonstration in the MolecuLight booth...
PR Newswire
02/11/2023

Nomination Committee appointed for SciBase Holding's Annual General Meeting in…

Dharminder Chahal (VanHerk Group), Dharminder Chahal(VanHerk Group), Peter Elmvik (Stockholms Elbolag), Tord Lendau (Chairman of the Board). The appointments have been made in accordance with the instructions regarding principles for the appointment of the company nominating committee which were determined at the Annual General Meeting of SciBase Holding onMay 17, 2023.The Annual General Meeting of SciBase Holding AB (publ) will be held onMay 17, 2024inStockholm...
PR Newswire
02/11/2023

Orexo Q3 2023 Interim Report

Q3 2023 highlights› Total net revenues of SEK 156.1 m (161.0)› EBITDA of SEK -9.5 m (-32.4), EBITDA excluding costs for legal processes and external non-­repeating ­­clinical trials, SEK 13.3 m (14.3) › Net earnings of SEK -33.3 m (-26.5)› US Pharma segment (ZUBSOLV® US) net revenues of SEK 140.4 m (150.1), in local currency USD 13.0 m (14.2), US Pharma EBIT of SEK 62.3 m (70.2)› Cash flow from operating activities of SEK -21.9 m (-60.7), cash and invested funds of SEK 184.2 m (443.9)› Earnings…
PR Newswire
02/11/2023

Ultimovacs ASA: Invitation to third quarter 2023 results webcast presentation

Oslo, November 2, 2023: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, invites to a webcast presentation of its third quarter 2023 results on Wednesday, November 8, 2023.The presentation can be followed as a live webcast accessed through a link on www.ultimovacs.com at 14:00 CET on Wednesday, November 8, 2023, and is scheduled to conclude at 14:55 CET. The webcast presentation will be available on the Ultimovacs...
Nasdaq GlobeNewswire
02/11/2023

SENISCA appoints Dr. Sarah Cole as Chief Executive Officer

SENISCA appoints Dr. Sarah Cole as Chief Executive OfficerExeter, UK — 02 November 2023:SENISCA SENISCA, a biotechnology company developing RNA based therapeutics to reverse cellular senescence and treat age-related disease, today announces that Sarah Cole, PhD., who previously served as Chief Operating Officer, has been appointed to the role of Chief Executive Officer. Kirsty Semple, who served as launch Chief Executive Officer since January 2020, will continue to play a pivotal role...
Nasdaq GlobeNewswire
02/11/2023

Novo Nordisk's sales increased by 29% in Danish kroner and by 33% at constant…

Bagsværd 2 November 2023 - Financial report for the period 1 January 2023 to 30 September 2023 Operating profit increased by 31% in Danish kroner and by 37% at constant exchange rates (CER) to DKK 75.8 billion.Sales in North America Operations increased by 46% in Danish kroner (49% at CER). Sales in International...
Nasdaq GlobeNewswire
02/11/2023

Addex Announces Participation in the Bio-Europe 2023 Conference

Geneva, Switzerland, November 2, 2023 - Addex Therapeutics(SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that Tim Dyer, Chief Executive Officer, and Dr. Mikhail Kalinichev, Head of Translational Science, will be attending theBio-Europe 2023 Conference (November 6 – 8, 2023) in Munich, Germany. A pre-recorded presentation, in which Mr. Dyer provides a corporate update and discusses...
Nasdaq GlobeNewswire
02/11/2023

Ultimovacs Announces Completion of Patient Enrollment in Supplementary Study to…

The supplementary study to INITIUM is designed to provide in-depth data on the biological activity and mode of action of the vaccine-induced T cells, to support the next stages of developmentEnrollment of 21 patients with unresectable or metastatic malignant melanoma completedAll patients received UV1 vaccination as an add-on to the checkpoint inhibitors ipilimumab and nivolumabOslo, November 2, 2023:Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology...
Nasdaq GlobeNewswire
02/11/2023

Xinhua Silk Road: 54th Zhangshu National Traditional Chinese Materia Medica…

Themed on inheritance and innovation, the fair has organized 19 activities including exhibitions, forums, and cultural events. Themed on inheritance and innovation, the fair has organized 19 activities including exhibitions, forums, and cultural events. During the fair, a pharmaceutical industry investment promotion conference was also held in Zhangshu, covering biomedical R&D and manufacturing, medical devices, traditional Chinese medicines prepared in ready-to-use forms and...
PR Newswire
02/11/2023

Chula Launches the Latest Parkinson's Gloves to Reduce Tremors

The current method of treating Parkinson's is taking a cocktail of medications, which is mostly unable to reduce all the tremors. Some patients whose tremors are especially strong may need brain surgery, which is an always undesirable option due to its high cost and many side effects. This conundrum has inspired a team of researchers at the Faculty of Medicine, Chulalongkorn University, led by Prof. Dr. Roongroj Bhidayasiri and Asst. Prof. Onanong Phokaewvarangkul, Ph.D. to research and develop…
PR Newswire
02/11/2023

Hospital Services Market to Reach $ 7.4 Trillion, Globally, by 2032 at 5.8%…

Request Sample of the Report on Hospital Services Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/127829 Request Sample of the Report on Hospital Services Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/127829 Hospital services serve as the foundation of a hospital's offerings and are often tailored to meet the needs and preferences of the hospital's primary users. The objective is to position the hospital as a comprehensive or...
PR Newswire
02/11/2023

NANOBIOTIX Announces Launch of Global Follow-On Offering and a Concurrent…

PARIS and CAMBRIDGE, Mass., Nov.01, 2023(GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the launch, subject to market and other conditions, of an approximately $30.0 million global follow-on offering (representing approximately €28.4 million) reserved to specified categories of investors...
Nasdaq GlobeNewswire
01/11/2023

TraceLink MINT Wins 2023 Pharma Innovation Award: 100% End-to-End Supply Chain…

The Pharma Innovation Awards are a testament to the commitment of vendors serving the pharmaceutical community in developing and enhancing their products to meet the evolving needs of the industry and its customers. TraceLink MINT has been recognized as a standout innovation, alongside esteemed companies such as Thermo Fisher Scientific and SCHOTT Pharma. The Pharma Innovation Awards are a testament to the commitment of vendors serving the pharmaceutical community in developing and enhancing...
PR Newswire
01/11/2023

Spinal Cord Injury Market Likely to Exhibit Substantial Growth by 2032, Assesses…

Key Takeaways from the Spinal Cord Injury Market Report Key Takeaways from the Spinal Cord Injury Market Report Discover which therapies are expected to grab the major spinal cord injury market share @Spinal Cord Injury Market Report Spinal Cord Injury Overview Spinal cord injury represents a significant medical condition that results in a wide range of functional, psychological, and socioeconomic challenges. Long-term complications are frequently encountered and play a...
PR Newswire
01/11/2023

Cellectis to Report Third Quarter 2023 Financial Results on November 6, 2023

The announcement will be followed by an investor conference call and webcast on Tuesday, November 7, 2023 at 8:00 AM ET / 2:00 PM CET. The call will include the Company's third quarter results and an update on business activities. Details for the call are as follows: Dial in information: Domestic: 1-877-451-6152International: 1-201-389-0879Conference ID: 13741035Webcast Link:https://viavid.webcasts.com/starthere.jsp?ei=1632799&tp_key=bff99741abAbout Cellectis ...
Nasdaq GlobeNewswire
01/11/2023

Jazz Pharmaceuticals to Participate in Upcoming November Investor Conferences

6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023 6 thAnnual Evercore ISI HealthCONx Conference onTuesday, November 28, 2023 2023 BofA Leveraged Finance Conference onWednesday, November 29, 2023 Audio webcasts of the presentations will be available via the Investors section of the Jazz Pharmaceuticals website athttps://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days...
PR Newswire
01/11/2023

Ireland's first medicinal cannabis clinic 'MEDICANN' is now open for patients

Through a virtual appointment, via our secure tele-health portal we can establish if you are eligible to be prescribed medicinal cannabis which comes in various forms flowers, oils and topical creams to help patients. Through a virtual appointment, via our secure tele-health portal we can establish if you are eligible to be prescribed medicinal cannabis which comes in various forms flowers, oils and topical creams to help patients. With an experienced team of local specialist consultants,...
PR Newswire
01/11/2023

Sobi has completed the issuances of series C shares

On 31 October 2023, the Board of Directors of Sobi resolved to issue 602,482 series C shares and to, conditional upon subscription and payment from Svenska Handelsbanken AB, repurchase all issued series C shares. Svenska Handelsbanken has today subscribed for 602,482 issued series C shares, and the new share issue is completed. The total issue proceeds amount to SEK 330,585.17 and have been paid on this day. On31 October 2023, the Board of Directors of Sobi resolved to issue 602,482 series C...
PR Newswire
01/11/2023

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 1 November 2023– On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023. Under…
Nasdaq GlobeNewswire
01/11/2023

Unilever Ventures and True Beauty Ventures Make Inaugural Investment in…

The 7 Virtues stands as a beacon of social and environmental consciousness pioneering the clean and sustainably sourced fragrance category. Founded in Canada in 2010 by entrepreneur, author and activist Barb Stegemann, the brand is the thesis of her best-selling book – The 7 Virtues of a Philosopher Queen – a woman's guide to living and leading in an illogical world. The 7 Virtues crafts perfumes that transcend the conventional, exuding benevolence to both our planet and the human soul. With a…
PR Newswire
01/11/2023

Dental Equipment Market size worth $ 17.68 Billion, Globally, by 2030 at 12.35%…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=5321 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=5321 Browse in-depth TOCon" Dental Equipment Market " 202 - Pages 126 – Tables 37 – Figures Global Dental Equipment Market: A Comprehensive Insight into Industry Trends and Challenges Verified Market Research®, recently released an in-depth report on the Dental Equipment Market, shedding light...
PR Newswire
01/11/2023

Multiplexed Diagnostics Market to Reach $41,477.13 Million, Globally, by 2032 at…

Request Sample of the Report on Multiplexed Diagnostics Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/15809 Request Sample of the Report on Multiplexed Diagnostics Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/15809 Detection of various analytes or targets in a single test or assey is referred to as multiplexed diagnostics. These play an essential role in drug development, by ehancing accuracy and efficiency to a great extent...
PR Newswire
01/11/2023

HUIDAGENE THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN MULTINATIONAL PHASE 1/2…

HG004 is an investigational gene replacement therapy product independently developed by HuidaGene. This HG004 therapy uses the recombinant AAV9 (AAV9) vector to deliver a functional human RPE65 gene to the retina and to restore, treat, and prevent blindness of children and adults with RPE65-IRDs. HG004 was granted both orphan drug designation (https://www.prnewswire.com/news-releases/huidagene-receives-orphan-drug-designation-for-gene-therapy-of-blindness-301787815.html) and rare pediatric…
PR Newswire
01/11/2023

Allergy Diagnostics Market size worth $ 13.12 Billion, Globally, by 2030 at…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=4094 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=4094 Browse in-depth TOCon" Allergy Diagnostics Market " 202 - Pages 126 – Tables 37 – Figures Global Allergy Diagnostics Market Insights Unveiled in Comprehensive Market Research Report The ever-evolving landscape of healthcare has seen an alarming surge in allergies, affecting millions...
PR Newswire
01/11/2023
Altri  Comunicati